3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Leukemia, Myeloid, Acute
1
Hypoxia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Radiosurgery
6
pembrolizumab
4
Carboplatin
3
atezolizumab
2
aldesleukin
2
Paclitaxel
2
Nivolumab
2
Cyclophosphamide
2
osimertinib
1
durvalumab
1
avelumab
1
amatuximab
1
Vitamin A
1
Tobacco Use Cessation Devices
1
Thoracic Surgical Procedures
1
Taxes
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
RXDX-106
1
Proton Therapy
1
Pemetrexed
1
Optical Fibers
1
Oncolytic Virotherapy
1
Itraconazole
1
Interleukin-2
1
Fluorodeoxyglucose F18
1
Ethiodized Oil
1
Erlotinib Hydrochloride
1
Docetaxel
1
Dihematoporphyrin Ether
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Carcinoma, Non-Small-Cell Lung
×
Atovaquone
×
Clear all
NCT02628080
2019-09-04
ATOM
University of Oxford
Phase EARLY_PHASE1
Completed
46 enrolled